<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Our aim was to determine the thoracic manifestations of patients with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (<z:chebi fb="21" ids="53713">APAs</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: We performed a retrospective review of the clinical records and thoracic imaging studies of 88 patients (63 women, 25 men; mean age 47 years) with <z:chebi fb="21" ids="53713">APAs</z:chebi> to determine the spectrum of <z:e sem="disease" ids="C0039978" disease_type="Disease or Syndrome" abbrv="">thoracic disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Nine patients (10%) had thoracic abnormalities, including eight with <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> (PE) and one with aortic <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>One patient with PE had subclavian vein <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Coexistent thromboses included <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo> of the leg in six patients </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: PE was the most common thoracic abnormality in our patients </plain></SENT>
<SENT sid="6" pm="."><plain>The presence of these antibodies should be suspected in patients with PE of otherwise unexplained etiology </plain></SENT>
</text></document>